Tianjin Ringpu Bio-Technology Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 900.28 million compared to CNY 1,029.95 million a year ago. Revenue was CNY 908.34 million compared to CNY 1,040.71 million a year ago.

Net income was CNY 139.83 million compared to CNY 203.59 million a year ago. Basic earnings per share from continuing operations was CNY 0.3026 compared to CNY 0.5127 a year ago. Diluted earnings per share from continuing operations was CNY 0.3026 compared to CNY 0.5127 a year ago.